For: | Salazar J, Pirela D, Nava M, Castro A, Angarita L, Parra H, Durán-Agüero S, Rojas-Gómez DM, Galbán N, Añez R, Chacín M, Diaz A, Villasmil N, De Sanctis JB, Bermúdez V. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int J Mol Sci 2022;23:3133. [PMID: 35328553 DOI: 10.3390/ijms23063133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Rangarajan S, Orujyan D, Rangchaikul P, Radwan MM. Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis. Biomedicines 2022;10:2829. [DOI: 10.3390/biomedicines10112829] [Reference Citation Analysis] |
2 | Marzec JM, Nadadur SS. Inflammation resolution in environmental pulmonary health and morbidity. Toxicol Appl Pharmacol 2022;449:116070. [PMID: 35618031 DOI: 10.1016/j.taap.2022.116070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis] |
3 | Kotlyarov S, Kotlyarova A. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis. Int J Mol Sci 2022;23. [PMID: 35563200 DOI: 10.3390/ijms23094808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis] |